This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Study published in New England Journal of Medicine employs Quest Diagnostics' blood-based leukemia testing MADISON, N.J., Feb. 20 /PRNewswire-FirstCall/ -- Testing of blood specimens may detect...
Quest Diagnostics Incorporated , the world's leading provider of diagnostic testing, information and services, today announced that its Board of...
- Diluted earnings per share of $0.87, up 10% - Total revenues of $1.8 billion, up 1.7% - Cash flow from operations improved to $363 million - 2009 EPS expected to be between $3.50 to $3.70 per...
Quest Diagnostics Incorporated , the world's leading provider of diagnostic testing, information and services, announced that its Board of...
Quest Diagnostics Incorporated , the world's leading provider of diagnostic testing, information and services, announced today that it will report...